28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/
Related
Religious schools should be aware of the ministerial exception, its potential application to certain...
Read More >
On January 1, 2017, Nevada became the fifth state to legalize the recreational use of marijuana. Sin...
Read More >
The UK rail industry has been severely impacted by the COVID-19 pandemic with large projects such as...
Read More >
Let's discuss some less-dramatic exit options for business owners (when they want to step away). Yo...
Read More >
In a highly unfavorable peer review decision, Leadbitter v. Keystone Anesthesia v. Petraglia, entere...
Read More >
On this episode of In-house Roundhouse, Rob DelPriore, Executive Vice President and General Counsel,...
Read More >